IntelGenx Announces First Parkinson's Disease Patients Dosed With Montelukast VersaFilm in Phase 2 'MONTPARK' Clinical Trial

SAINT LAURENT, Quebec, April 08, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that Montelukast VersaFilm has been administered to

GlobeNewswireApr 8 07:45 ET

IntelGenx Updates Status of Buprenorphine Buccal Film ANDA

SAINT LAURENT, Quebec, April 05, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that its co-developer, Chemo Research SL, through its agent and affiliate,

GlobeNewswireApr 5 07:45 ET

IntelGenx Technologies Corp. (PNK:IGXT) Q4 2023 Earnings Call Transcript

Yahoo FinanceMar 22 12:56 ET

Earnings Call Summary | Intelgenx Technologies Corp.(IGXT.US) Q4 2023 Earnings Conference

The following is a summary of the IntelGenx Technologies Corp. (IGXT) Q4 2023 Earnings Call Transcript:Financial Performance:IntelGenx reported Q4 total revenue of $426,000, a 146% increase compared t

moomoo AIMar 21 19:10 ET · Conference Call

IntelGenx GAAP EPS of -$0.01, Revenue of $0.43M

Seeking AlphaMar 21 07:49 ET

IntelGenx Technologies 4Q Rev $426,000 >IGX.T

IntelGenx Technologies 4Q Rev $426,000 >IGX.T

Dow JonesMar 21 07:32 ET